ArticleScientific reports2026
Data analysis of residents aged 40-59 in colorectal cancer screening in Pudong New Area, Shanghai, 2013-2023.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To analyse the colorectal cancer (CRC) screening results for residents aged 40–59 years in Shanghai’s Pudong New Area from 2013 to 2023; evaluate the initial screening outcomes, colonoscopy compliance, and the detection rates of intestinal lesions; and provide evidence to support the optimization of local CRC screening programs. This study included residents aged 40–59 years who participated in the CRC screening program in Pudong New Area from 2013 to 2023. A combined initial screening approach, consisting of a risk assessment questionnaire and a faecal occult blood test, was used to identify individuals with positive screening results who were then recommended for colonoscopy. The initial screening positivity rate, colonoscopy compliance rate, and detection rates of various intestinal lesions were calculated. The Cochran‒Armitage trend test was applied to assess temporal trends in these rates across the years of this study. Subgroup analyses stratified by sex and age group were conducted, with intergroup comparisons performed using the χ² test or Fisher’s exact test. A total of 231 574 participants (66.01% female) were included, of whom 36 148 were identified as positive in the initial screen (positivity rate: 15.61%). Among these participants, 10 999 underwent colonoscopy (compliance rate: 30.43%). Colonoscopy detected 3 403 cases of intestinal lesions (detection rate: 30.94%), including 132 cases of CRC, 829 cases of precancerous lesions, and 2 442 cases of other intestinal lesions. Overall, the initial screening positivity rate increased with age and was higher among males than females. Colonoscopy compliance did not differ significantly across age groups but was higher in males than in females. The detection rate of intestinal lesions varied significantly by age group, with males having higher rates than females did. Compared with females, males had 1–2 times higher detection rates for precancerous lesions, polyps, and other intestinal lesions. CRC screening among residents aged 40–59 years in the Pudong New Area contributes to CRC prevention and control. Efforts should focus on improving initial screening participation, particularly among males. Additionally, the current colonoscopy compliance rate among individuals with positive initial screening results (especially among females) remains low and requires further improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.